Drugs / betametazon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04875338 Comparator | Jan 2021 → Jan 2023 | epicondylitis | Istanbul University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | betametazon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04875338 ↗ |
| Known as | betamethasone sodium | “patients who will receive saline in 1 group and betamethasone sodium in a group will be selected in accordance with the specified conditions” NCT04875338 ↗ |
| Route | Other | “The injection will be applied to the point with a 23 g needle.” NCT04875338 ↗ |